Machelle Sanders - Feb 8, 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Jessica Dickerson, by power of attorney
Stock symbol
BCRX
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 04:06 PM
Previous filing
Jan 25, 2022
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Non-Qualified Stock Option Award $0 +26.7K $0.00 26.7K Feb 8, 2022 Common Stock 26.7K $17.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
F2 The option vests 1/36 per month for a period of 36 months, beginning on March 8, 2022.